56 related articles for article (PubMed ID: 11836560)
1. Immunohistochemical pattern of cytokeratins and MMPs in human keratinocyte cell lines of different biological behaviour.
Bachmeier BE; Nerlich AG
Int J Oncol; 2002 Mar; 20(3):495-9. PubMed ID: 11836560
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity.
Bachmeier BE; Nerlich AG; Lichtinghagen R; Sommerhoff CP
Anticancer Res; 2001; 21(6A):3821-8. PubMed ID: 11911253
[TBL] [Abstract][Full Text] [Related]
3. Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1,-8, and -13 and of TIMP-1.
Bachmeier BE; Nerlich AG; Boukamp P; Lichtinghagen R; Tschesche H; Fritz H; Fink E
Biol Chem; 2000; 381(5-6):509-16. PubMed ID: 10937883
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of TGF-(beta)s and their receptors in human keratinocyte cell lines of different biological behaviour.
Bachmeier BE; Ruoss I; Hagedorn HG; Nerlich AG
Int J Mol Med; 2002 Oct; 10(4):371-6. PubMed ID: 12239581
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases-2,-3,-7,-9 and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines.
Bachmeier BE; Boukamp P; Lichtinghagen R; Fusenig NE; Fink E
Biol Chem; 2000; 381(5-6):497-507. PubMed ID: 10937882
[TBL] [Abstract][Full Text] [Related]
6. mRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissue.
Jung M; Römer A; Keyszer G; Lein M; Kristiansen G; Schnorr D; Loening SA; Jung K
Prostate; 2003 May; 55(2):89-98. PubMed ID: 12661033
[TBL] [Abstract][Full Text] [Related]
7. Expression of laminin 5 by parental and c-Ha-ras-transformed HaCaT keratinocytes in organotypic cultures.
Zinn M; Aumailley M; Krieg T; Smola H
Eur J Cell Biol; 2006 May; 85(5):333-43. PubMed ID: 16460839
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression and activation of major matrix metalloproteinases in distinct topographic areas of invasive breast carcinomas.
Bachmeier BE; Rohrbach H; De Waal J; Jochum M; Nerlich AG
Int J Oncol; 2005 May; 26(5):1203-7. PubMed ID: 15809710
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evaluation of intermediate filament proteins in squamous papilloma and oral verrucous carcinoma.
Oliveira MC; Silveira EJ; Godoy GP; Amorim RF; Costa AL; Queiroz LM
Oral Dis; 2005 Sep; 11(5):288-92. PubMed ID: 16120114
[TBL] [Abstract][Full Text] [Related]
10. Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines.
Bachmeier BE; Albini A; Vené R; Benelli R; Noonan D; Weigert C; Weiler C; Lichtinghagen R; Jochum M; Nerlich AG
Exp Cell Res; 2005 Apr; 305(1):83-98. PubMed ID: 15777790
[TBL] [Abstract][Full Text] [Related]
11. Growth factor-enhanced expression and activity of matrix metalloproteases in human non-small cell lung cancer cell lines.
Bredin CG; Liu Z; Klominek J
Anticancer Res; 2003; 23(6C):4877-84. PubMed ID: 14981939
[TBL] [Abstract][Full Text] [Related]
12. Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines.
Daja MM; Niu X; Zhao Z; Brown JM; Russell PJ
Prostate Cancer Prostatic Dis; 2003; 6(1):15-26. PubMed ID: 12664060
[TBL] [Abstract][Full Text] [Related]
13. Effects of extracellular calcium on the growth-differentiation switch in immortalized keratinocyte HaCaT cells compared with normal human keratinocytes.
Micallef L; Belaubre F; Pinon A; Jayat-Vignoles C; Delage C; Charveron M; Simon A
Exp Dermatol; 2009 Feb; 18(2):143-51. PubMed ID: 18637039
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
Cancer Res; 2003 Dec; 63(23):8221-5. PubMed ID: 14678978
[TBL] [Abstract][Full Text] [Related]
15. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
Cardillo MR; Di Silverio F; Gentile V
Anticancer Res; 2006; 26(2A):973-82. PubMed ID: 16619495
[TBL] [Abstract][Full Text] [Related]
16. Implication of MT1-MMP in the maturation steps of benign melanocytic nevi.
Pérez LJ; Peñas PF; Atienzar M; García-Díez A
J Cutan Pathol; 2006 Feb; 33(2):139-44. PubMed ID: 16420309
[TBL] [Abstract][Full Text] [Related]
17. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves.
Dreger SA; Taylor PM; Allen SP; Yacoub MH
J Heart Valve Dis; 2002 Nov; 11(6):875-80; discussion 880. PubMed ID: 12479292
[TBL] [Abstract][Full Text] [Related]
18. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases.
Hagemann T; Robinson SC; Schulz M; Trümper L; Balkwill FR; Binder C
Carcinogenesis; 2004 Aug; 25(8):1543-9. PubMed ID: 15044327
[TBL] [Abstract][Full Text] [Related]
19. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
Haeusler G; Walter I; Helmreich M; Egerbacher M
Calcif Tissue Int; 2005 May; 76(5):326-35. PubMed ID: 15868281
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
